Patients with HOCM and severe LVOT obstruction can remain asymptomatic while significant cellular and structural changes of the heart (adverse remodeling) may occur preceding heart failure and rhythm disorders. Hence, preventing adverse remodeling through LVOT desobstruction may have significant impact on cardiac function and geometry in this particular population, as it is in symptomatic patients. The investigators will assess functional and structural characteristics of the myocardium in asymptomatic vs. symptomatic patients with severe LVOT obstruction before and after PTSMA, using advanced imaging studies with LGE-CMR and echocardiography.
The trial consists of three cohorts 1. Symptomatic HOCM patients with severe LVOT obstruction undergoing PTSMA (reference group) 2. Asymptomatic HOCM patients with severe LVOT obstruction undergoing PTSMA (study group) 3. Asymptomatic HOCM patients with severe LVOT obstruction with no intervention (observation group)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
15
Alcohol Septal Ablation
St. Antonius Hospital
Nieuwegein, Netherlands
NOT_YET_RECRUITINGSt. Antonius Hospital
Nieuwegein, Netherlands
RECRUITINGFibrosis
Extracellular Volume Fraction
Time frame: 2 years
Global longitudinal strain (TTE)
Diastolic Function
Time frame: 2 years
Deformation (CMR)
Shortening Index
Time frame: 2 years
Haemodynamics
Left and Right-Sided Pressure Gradients (TTE)
Time frame: 2 years
4D velocity mapping
Blood Flow
Time frame: 2 years
LV Geometry
Volume
Time frame: 2 years
New York Heart Association (NYHA) classification
Exercise tolerance
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.